Multiple Sclerosis

	11/27/2009	Multiple Sclerosis: Tempering Disabilities and Decline--Fundamentals for Managed Markets
	10/01/2009	Selecting Immunomodulating Therapy in Relapsing-Remitting Multiple Sclerosis
	10/01/2009	Delaying the Conversion of Clinically Isolated Syndrome to Relapsing-Remitting Multiple Sclerosis Through Early Intervention With Disease-Modifying Therapy
	10/01/2009	Delaying Disease Progression in Patients With MS Who Become Nonresponsive to Established Disease-Modifying Therapies
	07/23/2009	Evidence-Based Update for NPs and PAs in the Diagnosis and Management of Multiple Sclerosis
	03/23/2009	Multiple Sclerosis and Managed Care: Evidence-Based Approaches to Optimize Formulary Design and Patient Outcomes
	10/31/2008	New Data From the World Congress: First-Line Therapy, Modified Treatment, and Emerging Options in Multiple Sclerosis
	10/31/2008	Updates in Multiple Sclerosis: New Data on First-Line Therapy, Modified Treatment, and Emerging Options
	10/31/2008	Improving Outcomes in Newly Diagnosed Relapsing-Remitting MS: Focus on Early Intervention and Long-Term Treatment
	10/31/2008	Should We "Mess With Success?" Evaluating Modified Treatments and Dosing in Multiple Sclerosis
	10/31/2008	Emerging Strategies in Multiple Sclerosis: Innovative Agents and New Treatment Approaches
	10/16/2008	Current Issues and Ongoing Challenges in MS: Neurodegeneration and Neuroprotection
	10/03/2008	Decision-Making in an Era of Efficacious Biologics:  PML Complicating Rheumatic and Autoimmune Diseases and Their Therapies
	09/30/2008	Challenging Issues in the Management of Multiple Sclerosis
	07/24/2008	Advances in the Management and Treatment of Multiple Sclerosis
	07/03/2008	Concepts in the Treatment of MS: New Data on Standard Approaches and Future Possibilities
	07/03/2008	Long-Term Data on Initial Therapies for Relapsing-Remitting Multiple Sclerosis Support Early, Continuous Treatment
	07/03/2008	An Analysis of Data Supporting Early MS Treatment
	07/03/2008	Head-to-Head Comparisons of Initial Therapies for Relapsing-Remitting Multiple Sclerosis
	01/24/2008	Step-Wise Use of Immunomodulatory/Immunosuppressive Agents Provides Options in MS
	01/24/2008	Available Data on the Safety of Monoclonal Antibodies in MS
	01/24/2008	Oral Therapies May Expand Therapeutic Options in MS
	01/11/2008	B Cells With Likely Role in MS Pathogenesis
	01/11/2008	Standard and Novel Outcomes Show Efficacy of Monoclonal Antibodies in MS
	01/11/2008	Updated Safety Data for Monoclonal Antibodies in MS Generates Cautious Optimism